Unknown

Dataset Information

0

ERas Enhances Resistance to Cisplatin-Induced Apoptosis by Suppressing Autophagy in Gastric Cancer Cell.


ABSTRACT: Gastric cancer (GC), a common type of malignant cancer, remains the fifth most frequently diagnosed cancer and the third leading cause of cancer-related deaths worldwide. Despite developments in the treatment of GC, the prognosis remains poor. Embryonic stem cell-expressed Ras (ERas), a novel member of the Ras protein family, has recently been identified as an oncogene involved in the tumorigenic growth of embryonic stem cells. A recent study reported that ERas is expressed in most GC cell lines and GC specimens, and it promotes tumorigenicity in GC through induction of the epithelial mesenchymal transition (EMT) and activation of the PI3K/AKT pathway. Here, we found that ERas blocked autophagy flux in BGC-823 and AGS GC cells, which may occur through activation of the AKT/mTOR signaling pathway. Moreover, ERas overexpression suppressed cisplatin-induced apoptosis, and rapamycin treatment significantly attenuated ERas-mediated cisplatin resistance in GC cells. These data suggest that ERas may be a potential therapeutic target to improve the outcomes of GC patients by regulating the autophagy process.

SUBMITTER: Tian H 

PROVIDER: S-EPMC7005724 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

ERas Enhances Resistance to Cisplatin-Induced Apoptosis by Suppressing Autophagy in Gastric Cancer Cell.

Tian Huajian H   Wang Wenjun W   Meng Xiao X   Wang Miaomiao M   Tan Junyang J   Jia Wenjuan W   Li Peining P   Li Jianshuang J   Zhou Qinghua Q  

Frontiers in cell and developmental biology 20200121


Gastric cancer (GC), a common type of malignant cancer, remains the fifth most frequently diagnosed cancer and the third leading cause of cancer-related deaths worldwide. Despite developments in the treatment of GC, the prognosis remains poor. Embryonic stem cell-expressed Ras (ERas), a novel member of the Ras protein family, has recently been identified as an oncogene involved in the tumorigenic growth of embryonic stem cells. A recent study reported that ERas is expressed in most GC cell lines  ...[more]

Similar Datasets

| S-EPMC10257393 | biostudies-literature
| S-EPMC3956456 | biostudies-literature
| S-EPMC8521017 | biostudies-literature
| S-EPMC6488120 | biostudies-literature
| S-EPMC7533487 | biostudies-literature
| S-EPMC6103699 | biostudies-literature
| S-EPMC5816782 | biostudies-literature
| S-EPMC3229606 | biostudies-literature
| S-EPMC4511870 | biostudies-literature
| S-EPMC10129849 | biostudies-literature